Long‐term Combination of Interferon Alfa‐2b and Ribavirin for Hepatitis C Recurrence in Liver Transplant Patients

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis†

Robert G. Knodell, Kamal G. Ishak, William C. Black et al. · Hepatology · 1981 · 3.6K citations · Full text

Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C

John G. McHutchison, Stuart C. Gordon, Eugene R. Schiff et al. · New England Journal of Medicine · 1998 · 3.5K citations · Full text

Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus

Thierry Poynard, Patrick Marcellin, Samuel S. Lee et al. · The Lancet · 1998 · 2.3K citations

Interferon α2B, Hepatology, Hepatitis C +9

Interferon Alfa-2b Alone or in Combination with Ribavirin for the Treatment of Relapse of Chronic Hepatitis C

Gary L. Davis, Rafael Esteban, Vinod K. Rustgi et al. · New England Journal of Medicine · 1998 · 1.3K citations · Full text

Long-Term Outcome of Hepatitis C Infection after Liver Transplantation

Edward Gane, Bernard Portmann, Nikolai V. Naoumov et al. · New England Journal of Medicine · 1996 · 979 citations · Full text